Inactive Ingredient Search for Approved Drug Products
Search Names Beginning with V
| Inactive Ingredient | Route | Dosage Form | CAS Number | UNII | Maximum Potency per unit dose | Maximum Daily Exposure (MDE) | Record Updated |
|---|---|---|---|---|---|---|---|
| VALINE | INTRAVENOUS | INJECTION | 72184 | HG18B9YRS7 | 0.84%w/v | ||
| VALINE | INTRAVENOUS | INJECTION, SOLUTION | 72184 | HG18B9YRS7 | 0.2%w/v | ||
| VANILLA BEAN | ORAL | TABLET, ORALLY DISINTEGRATING | Q74T35078H | 1mg | |||
| VANILLIN | ORAL | CAPSULE | 121335 | CHI530446X | 0.94mg | ||
| VANILLIN | ORAL | CAPSULE, EXTENDED RELEASE | 121335 | CHI530446X | 0.94mg | ||
| VANILLIN | ORAL | ELIXIR | 121335 | CHI530446X | NA | ||
| VANILLIN | ORAL | LIQUID | 121335 | CHI530446X | NA | ||
| VANILLIN | ORAL | POWDER, FOR SUSPENSION | 121335 | CHI530446X | 2mg/1ml | ||
| VANILLIN | ORAL | SOLUTION | 121335 | CHI530446X | 2.5mg/5ml | ||
| VANILLIN | ORAL | SUSPENSION | 121335 | CHI530446X | 6mg | Y | |
| VANILLIN | ORAL | SYRUP | 121335 | CHI530446X | NA | ||
| VANILLIN | ORAL | TABLET | 121335 | CHI530446X | 12mg | ||
| VANILLIN | ORAL | TABLET, CHEWABLE | 121335 | CHI530446X | 2.5mg | ||
| VANILLIN | ORAL | TABLET, COATED | 121335 | CHI530446X | 65.5mg | ||
| VANILLIN | ORAL | TABLET, DELAYED RELEASE | 121335 | CHI530446X | 2mg | ||
| VANILLIN | ORAL | TABLET, EXTENDED RELEASE | 121335 | CHI530446X | 3.4mg | ||
| VANILLIN | ORAL | TABLET, FILM COATED | 121335 | CHI530446X | 5mg | ||
| VANILLIN | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 121335 | CHI530446X | 1mg | ||
| VANILLIN | ORAL | TABLET, ORALLY DISINTEGRATING | 121335 | CHI530446X | 0.26mg | ||
| VANILLIN | TOPICAL | OINTMENT | 121335 | CHI530446X | NA | ||
| VEGETABLE OIL | BUCCAL | GUM, CHEWING | 8008897 | NA | 14.4mg | ||
| VEGETABLE OIL | ORAL | CAPSULE | 8008897 | NA | 2mg | ||
| VEGETABLE OIL | ORAL | GRANULE, FOR SUSPENSION | 8008897 | NA | NA | ||
| VEGETABLE OIL | ORAL | SOLUTION | 8008897 | NA | NA | ||
| VEGETABLE OIL | ORAL | SUSPENSION, EXTENDED RELEASE | 8008897 | NA | NA | ||
| VEGETABLE OIL | ORAL | TABLET | 8008897 | NA | 25mg | ||
| VEGETABLE OIL | TOPICAL | CREAM | 8008897 | NA | 3.5%w/w | ||
| VEGETABLE OIL | TOPICAL | SOLUTION | 8008897 | NA | NA | ||
| VEGETABLE OIL GLYCERIDE, HYDROGENATED | ORAL | TABLET, EXTENDED RELEASE | NA | 77mg | |||
| VEGETABLE OIL GLYCERIDE, HYDROGENATED | RECTAL | SUPPOSITORY | NA | 870mg | |||
| VEGETABLE OIL, HYDROGENATED | ORAL | CAPSULE | 68334281 | NA | 311mg | ||
| VEGETABLE OIL, HYDROGENATED | ORAL | CAPSULE, EXTENDED RELEASE | 68334281 | NA | 37mg | ||
| VEGETABLE OIL, HYDROGENATED | ORAL | CAPSULE, LIQUID FILLED | 68334281 | NA | 4mg | ||
| VEGETABLE OIL, HYDROGENATED | ORAL | TABLET | 68334281 | NA | 42mg | ||
| VEGETABLE OIL, HYDROGENATED | ORAL | TABLET, CHEWABLE | 68334281 | NA | 8mg | ||
| VEGETABLE OIL, HYDROGENATED | ORAL | TABLET, COATED | 68334281 | NA | 2mg | ||
| VEGETABLE OIL, HYDROGENATED | ORAL | TABLET, EXTENDED RELEASE | 68334281 | NA | 2400mg | ||
| VEGETABLE OIL, HYDROGENATED | ORAL | TABLET, FILM COATED | 68334281 | NA | 12.3mg | ||
| VEGETABLE OIL, HYDROGENATED | RECTAL | SUPPOSITORY | 68334281 | NA | 1964.99mg | ||
| VEGETABLE OIL, HYDROGENATED | SUBLINGUAL | TABLET | 68334281 | NA | 3mg | ||
| VEGETABLE OIL, HYDROGENATED | TOPICAL | CREAM | 68334281 | NA | NA | ||
| VEGETABLE OIL, HYDROGENATED | VAGINAL | CREAM | 68334281 | NA | NA | ||
| VEGETABLE OIL, HYDROGENATED | VAGINAL | SUPPOSITORY | 68334281 | NA | 2295mg | ||
| VEGETABLE SHORTENING | ORAL | CAPSULE | NA | 10.56mg | |||
| VEGETABLE SHORTENING | ORAL | CAPSULE, LIQUID FILLED | NA | 17mg | |||
| VERSETAMIDE | INTRAVENOUS | INJECTION | 129009832 | N78PI4C683 | 25.4mg | ||
| VITAMIN E POLYETHYLENE GLYCOL SUCCINATE | ORAL | CAPSULE | 9002964 | O03S90U1F2 | 300mg | ||
| VITAMIN E POLYETHYLENE GLYCOL SUCCINATE | ORAL | SOLUTION | 9002964 | O03S90U1F2 | 300mg/1ml | ||
| VITAMIN E POLYETHYLENE GLYCOL SUCCINATE | ORAL | TABLET | 9002964 | O03S90U1F2 | 85mg | ||
| VITAMIN E POLYETHYLENE GLYCOL SUCCINATE | ORAL | TABLET, FILM COATED | 9002964 | O03S90U1F2 | 85mg |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: January 5, 2024
Database Last Updated: January 26, 2024